Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. TLT
9. PMTS
10. QQQ

Go back to Regeneron and Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients
Regeneron (NASDAQ: REGN) Delayed: 781.49 -11.77 (1.48%)
Previous Close $793.26    52 Week High $592.36 
Open $800.00    52 Week Low $325.35 
Day High $800.22    P/E 205.12 
Day Low $780.81    EPS $3.81 
Volume 443,989       

BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.96 +0.33 (2.26%)
Previous Close $14.63    52 Week High $5.58 
Open $14.90    52 Week Low $3.60 
Day High $14.96    P/E N/A 
Day Low $14.79    EPS $0.00 
Volume 6,576,624       

SANOFI (NASDAQ: SNY) Delayed: 42.77 +0.05 (0.12%)
Previous Close $42.72    52 Week High $44.76 
Open $42.81    52 Week Low $36.81 
Day High $42.89    P/E N/A 
Day Low $42.41    EPS $0.00 
Volume 2,373,014